Skip to main content

Overview of Adipose Tissue and Its Role in Obesity and Metabolic Disorders

  • Protocol

Part of the book series: Methods in Molecular Biology™ ((MIMB,volume 456))

Summary

As the result of its apparent structural and histological simplicity, adipose tissue (AT) functions initially were limited to energy storage, insulation, and thermoregulation. Only decades later was the extraordinarily dynamic role of AT recognized, revealing its participation in a broad range of physiological processes, including reproduction, apoptosis, inflammation, angiogenesis, blood pressure, atherogenesis, coagulation, fibrinolysis, immunity and vascular homeostasis with either direct or indirect implications in the regulation of proliferation. The functional pleiotropism of AT relies on its ability to synthesize and, in some cases, secrete a large number of enzymes, hormones, growth factors, cytokines, complement factors, and matrix and membrane proteins, collectively termed adipokines. At the same time, white AT expresses receptors for most of these factors, warranting a wide cross-talk at both local and systemic levels in response to metabolic changes or other external stimuli. In this chapter, mounting evidence on the specific characteristics of AT from different depots is outlined in relation to fat distribution and comorbidity development. The current knowledge in this field is reviewed with a broad perspective ranging from classification, structure, and distribution to the key functional roles of AT with a particular focus on the role of adipokines and their involvement in the metabolic disorders accompanying obesity.

This is a preview of subscription content, log in via an institution.

Buying options

Protocol
USD   49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Springer Nature is developing a new tool to find and evaluate Protocols. Learn more

References

  1. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM (1994) Positional cloning of the mouse obese gene and its human homologue. Nature 372:425–432

    Article  CAS  PubMed  Google Scholar 

  2. Langin D, Lafontan, M (2000) Millennium fat-cell lipolysis reveals unsuspected novel tracks. Horm Metab Res 32:443–452

    Article  CAS  PubMed  Google Scholar 

  3. Trayhurn P, Beattie JH (2001) Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proc Nutr Soc 60:329–339

    Article  CAS  PubMed  Google Scholar 

  4. Frühbeck G, Gómez-Ambrosi J, Muruzábal FJ, Burrell MA (2001) The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation. Am J Physiol 280:E827–E847

    Google Scholar 

  5. Frühbeck G, Gómez-Ambrosi J (2001) Rationale for the existence of additional adipostatic hormones. FASEB J 15:1996–2006

    Article  PubMed  Google Scholar 

  6. Frühbeck G (2001) A heliocentric view of leptin. Proc Nutr Soc 60:301–318

    Article  PubMed  Google Scholar 

  7. Marette A (2002) Mediators of cytokine-induced insulin resistance in obesity and other inflammatory settings. Curr Opin Clin Nutr Metab Care 5:377–383

    Article  CAS  PubMed  Google Scholar 

  8. Blake GJ, Ridker PM (2002) Inflammatory bio-markers and cardiovascular risk prediction. J Intern Med 252:283–294

    Article  CAS  PubMed  Google Scholar 

  9. Frühbeck G, Gómez-Ambrosi J (2003) Control of body weight: a physiologic and transgenic perspective. Diabetologia 46:143–172

    PubMed  Google Scholar 

  10. Trayhurn P, Wood IS (2004) Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 92:347–355

    Article  CAS  PubMed  Google Scholar 

  11. Frühbeck G (2004) The adipose tissue as a source of vasoactive factors. Curr Med Chem (Cardiovasc Hematol Agents) 2:197–208

    Article  Google Scholar 

  12. La Cava A, Alviggi C, Matarese G (2004) Unravelling the multiple roles of leptin in inflammation and autoimmunity. J Mol Med 82:4–11

    Article  CAS  PubMed  Google Scholar 

  13. Granger JP (2004) Inflammatory cytokines, vascular function, and hypertension. Am J Physiol Reg Integr Comp Physiol 286:R989–R990

    CAS  Google Scholar 

  14. Gimeno RE, Klaman LD (2005) Adipose tissue as an active endocrine organ: recent advances. Curr Opin Pharmacol 5:122–128

    Article  CAS  PubMed  Google Scholar 

  15. Hutley L, Prins JB (2005) Fat as an endocrine organ: relationship to the metabolic syndrome. Am J Med Sci 330:280–289

    Article  PubMed  Google Scholar 

  16. Trayhurn, P (2005) Endocrine and signalling role of adipose tissue: new perspectives on fat. Acta Physiol Scand 184:285–293

    Article  CAS  PubMed  Google Scholar 

  17. Yu Y-H, Ginsberg HN (2005) Adipocyte signaling and lipid homeostasis. Sequelae of insulin-resistant adipose tissue. Circ Res 96:1042–1052

    Article  CAS  PubMed  Google Scholar 

  18. Bell CG, Walley AJ, Froguel P (2005) The genetics of human obesity. Nat Rev Genet 6:221–234

    Article  CAS  PubMed  Google Scholar 

  19. Berg AH, Scherer PE (2005) Adipose tissue, inflamation and cardiovascular disease. Circ Res 96:939–949

    Article  CAS  PubMed  Google Scholar 

  20. Lau DCW, Dhillon B, Yan H, Szmitko PE, Verma, S (2005) Adipokines: molecular links between obesity and atherosclerosis. Am J Physiol Heart Circ Physiol 288:H2031–H2041

    Article  CAS  PubMed  Google Scholar 

  21. Nawrocki AR, Scherer PE (2005) Adipose tissue, adipokines, and inflammation. Drug Discovery Today 10:1219–1230

    Article  CAS  PubMed  Google Scholar 

  22. Fantuzzi G (2005) Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 115:911–919

    Article  CAS  PubMed  Google Scholar 

  23. Van Gaal LF, Mertens IL, De Block CE (2006) Mechanisms linking obesity with cardiovascular disease. Nature 444:875–880

    Article  PubMed  Google Scholar 

  24. Kahn SE, Hull RL, Utzschneider KM (2006) Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444:840–846

    Article  CAS  PubMed  Google Scholar 

  25. Fain JN (2006) Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells. Vitam Horm 74:443–477

    Article  CAS  PubMed  Google Scholar 

  26. Matsuzawa Y (2006) Therapy insight: adipocytokines in metabolic syndrome and related cardiovascular disease. Nat Clin Pract Cardiovasc Med 3:35–42

    Article  CAS  PubMed  Google Scholar 

  27. Trayhurn P, Bing C, Wood IS (2006) Adipose tissue and adipokines—energy regulation from the human perspective. J Nutr 136:1935S–1939S

    CAS  PubMed  Google Scholar 

  28. Despres JP, Lemieux I (2006) Abdominal obesity and metabolic syndrome. Nature 444:881–887

    Article  CAS  PubMed  Google Scholar 

  29. Abizaid A, Gao Q, Horvath TL (2006) Thoughts for food: brain mechanisms and peripheral energy balance. Neuron 51:691–702

    Article  CAS  PubMed  Google Scholar 

  30. Pond CM (1999) Physiological specialisation of adipose tissue. Prog Lipid Res 38:225–248

    Article  CAS  PubMed  Google Scholar 

  31. Spiegelman BM, Hotamisligil GS, Graves RA, Tontonoz P (1993) Regulation of adipocyte gene expression and syndromes of obesity/diabetes. J Biol Chem 268:68236–6826

    Google Scholar 

  32. Rosen ED, Walkey CJ, Puigserver P, Spiegelman BM (2000) Transcriptional regulation of adipogenesis. Genes Dev 14:1293–1307

    CAS  PubMed  Google Scholar 

  33. Gregoire FM (2001) Adipocyte differentiation: from fibroblast to endocrine cell. Exp Biol Med 226:997–1002

    CAS  Google Scholar 

  34. Rosen ED, MacDougald OA (2006) Adipocyte differentiation from the inside out. Nat Rev Mol Cell Biol 7:885–896

    Article  CAS  PubMed  Google Scholar 

  35. Unger RH (2003) The physiology of cellular liporegulation. Annu Rev Physiol 65:333–347

    Article  CAS  PubMed  Google Scholar 

  36. Shen W, Wang Z, Punyanita M, Lei J, Sinav A, Kral JG, Imielinska C, Ross R, Heymsfield SB (2003) Adipose quantification by imaging methods: a proposed classification. Obesity Res 11:5–16

    Article  Google Scholar 

  37. Cannon B, Nedergaard, J (2004) Brown adipose tissue: function and physiological significance. Physiol Rev 84:277–359

    Article  CAS  PubMed  Google Scholar 

  38. Wajchenberg BL (2000) Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocrine Rev 21:697–738

    Article  CAS  Google Scholar 

  39. Lafontan M, Berlan M (2003) Do regional differences in adipocyte biology provide new patho-physiological insights? Trends Pharmacol Sci 24:276–283

    Article  CAS  PubMed  Google Scholar 

  40. Fried SK, Ross RR (2004) Biology of visceral adipose tissue. In: Bray GA, Bouchard C (eds) Handbook of obesity. Etiology and pathophysiology, 2nd edn. Marcel Dekker, Inc., New York, pp 589–614

    Google Scholar 

  41. Gómez-Ambrosi J, Catalán V, Diez-Caballero A, Martínez-Cruz A, Gil MJ, García-Foncillas J, Cienfuegos JA, Salvador J, Mato JM, Frühbeck G (2004) Gene expression profile of omental adipose tissue in human obesity. FASEB J 18:215–217

    PubMed  Google Scholar 

  42. Linder K, Arner P, Flores-Morales A, Tollet-Egnell P, Norstedt G (2004) Differentially expressed genes in visceral and subcutaneous adipose tissue of obese men and women. Prog Lipid Res 45:148–154

    CAS  Google Scholar 

  43. Schäffler A, Schölmerich J, Buechler C (2006) The role of ‘adipotropins’ and the clinical importance of a potential hypothalamic-pituitary-adipose axis. Nat Clin Pract Endocrinol Metab 2:374–383

    Article  PubMed  Google Scholar 

  44. Jump DB (2004) Fatty acid regulation of gene transcription. Crit Rev Clin Lab Sci 41:41–78

    Article  CAS  PubMed  Google Scholar 

  45. Cousin B, Munoz O, Andre M, Fontanilles AM, Dani C, Cousin JL, et al (1999) A role for preadipocytes as macrophage-like cells. FASEB J 13:305–312

    CAS  PubMed  Google Scholar 

  46. Peeraully MR, Jenkins JR, Trayhurn P (2004) NGF gene expression and secretion in white adipose tissue: regulation in 3T3-L1 adipocytes by hormones and inflammatory cytokines. Am J Physiol Endocrinol Metab 287:E331–E339

    Article  CAS  PubMed  Google Scholar 

  47. Wang B, Jenkins JR, Trayhurn, P (2005) Expression and secretion of inflammation-related adipokines by human adipocytes differentiated in culture: integrated response to TNF-α. Am J Physiol Endocrinol Metab 288:E731–E740

    Article  CAS  PubMed  Google Scholar 

  48. Lehrke M, Reilly MP, Millington SC, Iqbal N, Rader DJ, Lazar MA (2004) An inflammatory cascade leading to hyper-resistinemia in humans. PloS Med 1:161–168

    Article  CAS  Google Scholar 

  49. Frühbeck G (2006) Vasoactive factors and inflammatory mediators produced in adipose tissue. In: Fantuzzi G, Mazzone T (eds) Health and nutrition. Adipose tissue and adipokines in health and disease. Humana Press Inc., Totowa, NJ, pp 61–75

    Google Scholar 

  50. Chaldakov GN, Tonchev AB, Tuncel N, Atanassova P, Aloe L. Adipose tissue and mast cells. Adipokines as yin-yang modulators of inflammation. In: Fantuzzi G, Mazzone T, (eds) Health and nutrition. Adipose tissue and adipokines in health and disease. Humana Press Inc., Totowa, NJ, pp 147–154

    Google Scholar 

  51. Murdolo G, Smith U (2006) The dysregulated adipose tissue: a connecting link between insulin resistance, type 2 diabetes mellitus and atherosclerosis. Nutr Metab Cardiovasc Dis 16:S35–S38

    Article  PubMed  Google Scholar 

  52. Shoelson SE, Lee J, Goldfine AB (2006) Inflammation and insulin resistance. J Clin Invest 116:1793–1801

    Article  CAS  PubMed  Google Scholar 

  53. Wenger RH (2002) Cellular adaptation to hypoxia: O2-sensing protein hydroxylases, hypoxia-inducible transcription factors, and O2-regulated gene expression. FASEB J 16:1151–1162

    Article  CAS  PubMed  Google Scholar 

  54. Fearnly GR, Vincent CT, Chakrabarti R (1959) Reduction of blood fibrinolytic activity in diabetes mellitus by insulin. Lancet 2:1067

    Article  Google Scholar 

  55. Ogston D, McAndrew GM (1964) Fibrinolysis in obesity. Lancet 14:1205–1207

    Article  Google Scholar 

  56. Grace CS, Goldrick RB (1968) Fibrinolysis.and body build. Interrelationships between blood fibrinolysis, body composition and parameters of lipid and carbohydrate metabolism. J Atheroscler Res 8:705–719

    Article  CAS  PubMed  Google Scholar 

  57. Schmidt MI, Duncan BB, Sharrett AR, Lindberg G, Savage PJ, Offenbacher S, et al (1999) Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study. Lancet 353:1649–1652

    Article  CAS  PubMed  Google Scholar 

  58. Barzilay JI, Abraham L, Heckbert SR, Cushman M, Kuller LH, Resnick HE, et al (2001) The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study. Diabetes 50:2384–2389

    Article  CAS  PubMed  Google Scholar 

  59. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM (2001) C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286:327–334

    Article  CAS  PubMed  Google Scholar 

  60. Festa A, D'Agostino R Jr., Tracy RP, Haffner SM (2002) Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes 51:1131–1137

    Article  CAS  PubMed  Google Scholar 

  61. Freeman DJ, Norrie J, Caslake, MJ, Gaw A, Ford I, Lowe GD, et al (2002) C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes 51:1596–1600

    Article  CAS  PubMed  Google Scholar 

  62. Haffner S, Temprosa M, Crandall J, Fowler S, Goldberg R, Horton E, et al (2005) Intensive lifestyle intervention or metformin on inflammation and coagulation in participants with impaired fasting glucose tolerance. Diabetes 54:1566–1572

    Article  PubMed  Google Scholar 

  63. Linton MF, Fazio S (2003) Macrophages, inflammation, and atherosclerosis. Int J Obes Relat Metab Disord 27(Suppl 3):S35–S40

    Article  CAS  PubMed  Google Scholar 

  64. Castrillo A, Tontonoz P (2004) Nuclear receptors in macrophage biology: at the crossroads of lipid metabolism and inflammation. Annu Rev Cell Dev Biol 20:455–480

    Article  CAS  PubMed  Google Scholar 

  65. Clément K, Viguerie N, Poitou C, Carette C, Peñoux V, Curat CA, et al (2004) Weight loss regulates inflammation-related genes in white adipose tissue of obese subjects. FASEB J 18:1657–1669

    Article  PubMed  Google Scholar 

  66. Poitou C, Viguerie N, Cancello R, De Matteis R, Cinti S, Stich, V. et al (2005) Serum amyloid A: production by human white adipocyte and regulation by obesity and nutrition. Diabetologia 48:519–528

    Article  CAS  PubMed  Google Scholar 

  67. Charo IF, Taubman MB (2004) Chemokines in the pathogenesis of vascular disease. Circ Res 95:858–866

    Article  CAS  PubMed  Google Scholar 

  68. Malavazos AE, Cereda E, Morricone L, Coman C, Corsi MM, Ambrosi B (2005) Monocyte chemoattractant protein 1: a possible link between visceral adipose tissue-associated inflammation and subclinical echocardiographic abnormalities in uncomplicated obesity. Eur J Endocrinol 153:871–877

    Article  CAS  PubMed  Google Scholar 

  69. Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, Kishimoto K, et al (2005) Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 307:426–430

    Article  CAS  PubMed  Google Scholar 

  70. Berndt J, Kloting N, Kralisch S, Kovacs P, Fasshauer M, Schon MR, et al (2005) Plasma visfatin concentrations and fat depot-specific mRNA expression in humans. Diabetes 54:2911–2916

    Article  CAS  PubMed  Google Scholar 

  71. Yang Q, Graham TE., Mody N, Preitner F, Peroni OD., Zabolotny JM, et al (2005) Serum retinol binding protein 4 contributes to insulin resistance and type 2 diabetes. Nature 436:356–362

    Article  CAS  PubMed  Google Scholar 

  72. Cancello R, Clement, K (2006) Is obesity an inflammatory illness? Role of low-grade inflammation and macrophage infiltration in human white adipose tissue. BJOG 113:1141–1147

    Article  CAS  PubMed  Google Scholar 

  73. Arner P (2006) Visfatin—a true or false trail to type 2 diabetes mellitus. J Clin Endocrinol Metab 91:28–30

    Article  CAS  PubMed  Google Scholar 

  74. Graham TE, Yang Q, Blüher M, Hammarstedt A, Ciaraldi TP, Henry RR, et al (2006) Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med 354:2552–2563

    Article  CAS  PubMed  Google Scholar 

  75. Cho YM, Youn BS, Lee H, Lee N, Min SS, Kwak SH, et al (2006) Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes. Diabetes Care 29:2457–2461

    Article  CAS  PubMed  Google Scholar 

  76. Janke J, Engeli S, Boschmann M, Adams F, Bohnke J, Luft FC, et al (2006) Retinol-binding protein 4 in human obesity. Diabetes 55:2805–2810

    Article  CAS  PubMed  Google Scholar 

  77. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS (2006) TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 116:3015–3025

    Article  CAS  PubMed  Google Scholar 

  78. Song MJ, Kim KH., Yoon JM, Kim JB (2006) Activation of Toll-like receptor 4 is associated with insulin resistance in adipocytes. Biochem Biophys Res Commun 346:739–745

    Article  CAS  PubMed  Google Scholar 

  79. Hotamisligil GS (2006) Inflammation and metabolic disorders. Nature 444:860–867

    Article  CAS  PubMed  Google Scholar 

  80. Tilg H, Moschen AR (2006) Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 6:772–783

    Article  CAS  PubMed  Google Scholar 

  81. Lumeng CN, Bodzin JL, Saltiel AR (2007) Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 117:175–184

    Article  CAS  PubMed  Google Scholar 

  82. Lumeng CN, Deyoung SM, Bodzin JL, Saltiel AR (2007) Increased inflammatory properties of adipose tissue macrophages recruited during diet-induced obesity. Diabetes 56:16–23

    Article  CAS  PubMed  Google Scholar 

  83. Choudhury J, Sanyal AJ (2004) Clinical aspects of fatty liver disease. Semin Liver Dis 24:349–362

    Article  PubMed  Google Scholar 

  84. Roden M (2006) Mechanisms of disease: hepatic steatosis in type 2 diabetes—pathogenesis and clinical relevance. Nat Clin Pract Endocrinol Metab 2:335–348

    Article  CAS  PubMed  Google Scholar 

  85. Tilg H, Hotamisligil GS (2006) Nonalcoholic fatty liver disease: Cytokine-adipokine interplay and regulation of insulin resistance. Gastroenterology 131:934–945

    Article  CAS  PubMed  Google Scholar 

  86. Utzschneider KM, Kahn SE (2006) The role of insulin resistance in nonalcoholic fatty liver disease. J Clin Endocrinol Metab 91:4753–4761

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by FIS PI061458 from the Spanish Instituto de Salud Carlos III, Ministerio de Sanidad y Consumo and by the Department of Health of the Gobierno de Navarra (20/2005) of Spain.

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Humana Press, a part of Springer Science+Business Media, LLC

About this protocol

Cite this protocol

Frühbeck, G. (2008). Overview of Adipose Tissue and Its Role in Obesity and Metabolic Disorders. In: Yang, K. (eds) Adipose Tissue Protocols. Methods in Molecular Biology™, vol 456. Humana Press. https://doi.org/10.1007/978-1-59745-245-8_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-245-8_1

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-916-1

  • Online ISBN: 978-1-59745-245-8

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics